Consolidation treatment of advanced ovarian carcinoma with radiotherapy after induction chemotherapy

International Journal of Gynecological Cancer

Volumn 13, Issue SUPPL. 2, 2003, Pages 192-195

  Sorbe, B ^a  

^a ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Consolidation therapy; Ovarian carcinoma; Radiotherapy

Indexed keywords

CISPLATIN; DOXORUBICIN; EPIRUBICIN;

ADULT; ADVANCED CANCER; AGED; BLOOD TOXICITY; BONE MARROW DEPRESSION; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOSE RESPONSE; DYSURIA; FEMALE; HISTOPATHOLOGY; HUMAN; INTESTINE OBSTRUCTION; MAJOR CLINICAL STUDY; MINIMAL RESIDUAL DISEASE; OVARY CARCINOMA; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL; RELAPSE; RISK BENEFIT ANALYSIS; SIDE EFFECT; TUMOR RECURRENCE;

EID: 1242320041     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1136/ijgc-00009577-200311001-00011     Document Type: Conference Paper

References (23)

1. Ho AG, Beller U, Speyer JL, Colombo N, Wernz J, Beckman EM. A reassessment of the role of second-look laparotomy in advanced ovarian cancer. J Clin Oncol 1987;5:1316-21.
2. Lund B, Williamson P. Prognostic factors for outcome of and survival after second-look laparotomy in patients with advanced ovarian carcinoma. Obstet Gynecol 1990;76:617-22.
3. Rubin S, Hoskins W, Saigo P et al. Prognostic factors for recurrence following negative second-look laparotomy in ovarian cancer patients treated with platinum-based chemotherapy. Gynecol Oncol 1991;42:137-41.
4. Vermorken JB. Consolidation therapy in patients with advanced ovarian cancer. Eur J Gynaecol Oncol 1994;15:7-13.
5. MacGibbon A, Bucci J, MacLeod C et al. Whole abdominal radiotherapy following second-look laparotomy for ovarian carcinoma. Gynecol Oncol 1999;75:62-7.
6. Rothenberg ML, Liu PY, Wilczynski S et al. Phase II trial of oral altretamine for consolidation of clinical complete remission in women with stage III epithelial ovarian cancer: a Southwest Oncology Group trial (SWOG-9326). Gynecol Oncol 2001;82:317-22.
7. Markman M. Weekly paclitaxel in the management of ovarian cancer. Semin Oncol 2000;27:37-40.
8. Dembo AJ, Bush RS, Beale FA et al. Improved survival following abdominopelvic irradiation in patients with a completed pelvic operation. Am J Obstet Gynecol 1979;134:793-800.
9. Fuller DB, Sause WT, Plenk HP et al. Analysis of postoperative radiation therapy in stage I through III epithelial ovarian carcinoma. J Clin Oncol 1987;5:897-902.
10. Thomas GM. Is there a role for consolidation or salvage radiotherapy after chemotherapy in advanced epithelial ovarian cancer? Gynecol Oncol 1993;51:97-103.
11. Thomas GM, Dembo AJ. Integrating radiation therapy into the management of ovarian cancer. Cancer 1993;71:1710-8.
12. Dembo AJ. Epithelial ovarian cancer: the role of radiotherapy. Int J Radiat Oncol Biol Phys 1992;22:835-45.
13. Withers HR, Peters LJ, Taylor JMG. Dose-response relationship for radiation therapy of subclinical disease. Int J Radiat Oncol Biol Phys 1995;31:353-9.
14. Withers HR, Suwinski R. Radiation dose response for subclinical metastases. Semin Radiat Oncol 1998;8:224-8.
15. Kapp KS, Kapp DS, Poschauko J et al. The prognostic significance of peritoneal seeding and size of postsurgical residual in patients with stage III epithelial ovarian cancer treated with surgery, chemotherapy, and high-dose radiotherapy. Gynecol Oncol 1999;74:400-7.
16. Buser K, Bacchi M, Goldhirsch A et al. Treatment of ovarian cancer with surgery, short-course chemotherapy and whole abdominal radiation. Ann Oncol 1996;7:65-70.
17. Lambert HE, Rustin GJ, Gregory WM, Nelstrop AE. A randomized trial comparing single-agent carboplatin with carboplatin followed by radiotherapy for advanced ovarian cancer: a North Thames Ovary Group Study. J Clin Oncol 1993;11:440-8.
18. Pickel H, Petru E, Lahousen M et al. Consolidation radiotherapy following carboplatin-based chemotherapy in radically operated advanced ovarian cancer. A pilot study. Am J Clin Oncol 1991;14:184-7.
19. Goldhirsch A, Greiner R, Dreher E et al. Treatment of advanced ovarian cancer with surgery, chemotherapy, and consolidation of response by whole-abdominal radiotherapy. Cancer 1988;62:40-7.
20. Fuks Z, Rizel S, Biran S. Chemotherapeutic and surgical induction of pathological complete remission and whole abdominal irradiation for consolidation does not enhance the cure of stage III ovarian cancer. J Clin Oncol 1988;6:509-16.
21. Kuten A, Stein M, Steiner M, Rubinov R, Epelbaum R, Cohen Y. Whole abdominal irradiation following chemotherapy in advanced ovarian carcinoma. Int J Radiat Oncol Biol Phys 1988;14:273-9.
22. Dufour P, Bergerat JP, Liu KL et al. High dose melphalan and ABMT with or without abdominal radiotherapy as consolidation treatment for ovarian carcinoma in complete remission or with microscopic residual disease. Eur J Gynaecol Oncol 1991;12:457-61.
23. Lawton F, Luesley D, Blackledge G et al. A randomized trial comparing whole abdominal radiotherapy with chemotherapy following cisplatinum cytoreduction in epithelial ovarian cancer. West Midlands Ovarian Cancer Group trial II. Clin Oncol 1990;2:4-9.